🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial is a multicentre, prospective, randomised controlled, unblinded, ...
Status
Terminated
Location
Humanitas Research Hospital
Start Date
2014-11
Trial ID
NCT02323360
The purpose of this study is to determine the feasibility and toxicity of c...
Status
Withdrawn
Location
UPMC Presbyterian/Montifore
Start Date
2009-07
Trial ID
NCT00746655
Treatments Being Tested
The efficacy and safety of HAIC combined with tyrosine kinase inhibitor and...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2021-11-05
Trial ID
NCT05135364
Treatments Being Tested
The purpose of this study is to determine whether compared with arsenic tri...
Status
Unknown
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01861912
Treatments Being Tested
This is a pilot study with a single arm in a single center assessing safety...
Status
Unknown
Location
Multiple Locations
Start Date
2021-07
Trial ID
NCT04517227
Treatments Being Tested
The purpose of the study is to assess the survival of patients treated with...
Status
Completed
Location
University Hospital Dubrava
Start Date
2006-07
Trial ID
NCT00355355
Huge hepatocellular carcinoma (HCC) is defined as a tumor with a maximum di...
Status
Recruiting
Location
Chinese PLA general hospital
Start Date
2025-01-01
Trial ID
NCT06898398
This study is a multicentre, prospective, randomised trial, aims to evaluat...
Status
Recruiting
Location
Bo Zhang
Start Date
2023-06-10
Trial ID
NCT05794971
Treatments Being Tested
Aim of this study is to evaluate whether treating HCC recurrences in resect...
Status
Completed
Location
Department of Surgery "Pietro Valdoni"
Start Date
2018-01-01
Trial ID
NCT03875417
Treatments Being Tested
This is a phase IB study design planned to identify the MTD (Maximum Tolera...
Status
Withdrawn
Location
The University of Michigan Comprehensive Cancer Center
Start Date
2017-07
Trial ID
NCT02997956
Treatments Being Tested